Our combined comparative gene expression and pan-cancer analysis revealed that FABP7 levels remodel cancer-associated pathways and identify oncogenic and tumor-immune modulatory factors that enhance immunosuppressive infiltrates, significantly impacting clinical outcomes in brain cancers, particularly LGG. Here, FABP7 is linked to cancer.